[HTML][HTML] Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
B Buijsers, C Yanginlar, ML Maciej-Hulme… - …, 2020 - thelancet.com
… doses of heparin/LMWH in COVID-19 patients. In addition, identification of specific heparin-…
potential for COVID-19 patients, and patients suffering from other inflammatory diseases. …
potential for COVID-19 patients, and patients suffering from other inflammatory diseases. …
Potential of heparin and nafamostat combination therapy for COVID‐19
… of COVID-19. Tang et al reported that heparin (particularly low molecular weight heparin) …
In Japan, anticoagulants used for DIC include heparin as well as antithrombin concentrates, …
In Japan, anticoagulants used for DIC include heparin as well as antithrombin concentrates, …
Heparin as a therapy for COVID-19: current evidence and future possibilities
JA Hippensteel, WB LaRiviere… - … of Physiology-Lung …, 2020 - journals.physiology.org
… Finally, we discuss potential risks associated with the implementation of heparin for the
treatment of SARS-CoV-2, including but not limited to bleeding and immune-mediated …
treatment of SARS-CoV-2, including but not limited to bleeding and immune-mediated …
Comprehensive landscape of heparin therapy for COVID-19
C Shi, W Tingting, JP Li, MA Sullivan, C Wang… - Carbohydrate …, 2021 - Elsevier
… In this review, we comprehensively discussed the potential of heparin therapy for COVID-19.
With multi-functions including its anticoagulant, anti-inflammatory and antiviral activities, …
With multi-functions including its anticoagulant, anti-inflammatory and antiviral activities, …
The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID‐19 patients: a retrospective cohort study
C Shi, C Wang, H Wang, C Yang, F Cai… - Clinical and …, 2020 - Wiley Online Library
… of LMWH as a potential therapeutic drug for the treatment of COVID-19, paving the way …
heparin/LMWH for the treatment of COVID-19, our study signifies an additional activity of heparin …
heparin/LMWH for the treatment of COVID-19, our study signifies an additional activity of heparin …
[HTML][HTML] Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis
… These findings come against several preliminary reports suggesting the potential role of
heparin in reducing mortality [5]. Meanwhile, regression models (Fig. 1b) revealed no significant …
heparin in reducing mortality [5]. Meanwhile, regression models (Fig. 1b) revealed no significant …
[HTML][HTML] The benefits of heparin use in COVID-19: pleiotropic antiviral activity beyond anticoagulant and anti-inflammatory properties
… for the importance of heparin usage in COVID-19.[27] In fact, the antiviral activity of heparin
may … sprays are undergoing clinical trials to evaluate their potential to mitigate SARS-CoV-2 …
may … sprays are undergoing clinical trials to evaluate their potential to mitigate SARS-CoV-2 …
Heparin for moderately ill patients with Covid-19
… , in addition to its anticoagulant properties, has anti-inflammatory and potential anti… heparin
compared with usual care using lower doses of heparin in hospitalized patients with Covid-19…
compared with usual care using lower doses of heparin in hospitalized patients with Covid-19…
Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia
L Costanzo, FP Palumbo, G Ardita, PL Antignani… - Journal of Vascular …, 2020 - Elsevier
… and a potential antiviral effect. We hypothesized that low-molecular-weight heparin may
attenuate cytokine storm in COVID-19 … In this paper, we review potential mechanisms involved in …
attenuate cytokine storm in COVID-19 … In this paper, we review potential mechanisms involved in …
… and Haemostasis challenges in COVID-19–Therapeutic perspectives of heparin and tissue-type plasminogen activator and potential toxicological reactions-a mini …
… of heparin and tPA in the treatment of COVID-19-induced ARDS and their related potential
physio-… in COVID infection and the potential toxicologic reactions associated with these drugs. …
physio-… in COVID infection and the potential toxicologic reactions associated with these drugs. …
相关搜索
- patients with covid 19 potential role
- therapeutic dose heparin covid 19
- heparin therapy covid 19
- low molecular weight heparin covid 19
- moderately ill patients with covid 19
- coagulopathy in covid 19
- meta analysis covid 19
- heparin in covid 19 thromboembolic complications
- therapeutic anticoagulation covid 19
- heparin in covid 19 two years
- multiple potential targets covid 19 therapy
- systemic heparin treatment of covid 19
- unfractionated heparin covid 19
- thromboprophylaxis in covid 19
- challenges in covid 19
- covid 19 patients